Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$90.19 - $110.4 $17,496 - $21,417
194 Added 0.78%
24,977 $2.75 Million
Q3 2023

Nov 14, 2023

BUY
$95.53 - $114.62 $2.37 Million - $2.84 Million
24,783 New
24,783 $2.4 Million
Q1 2023

May 15, 2023

BUY
$96.86 - $114.01 $372,039 - $437,912
3,841 Added 25.5%
18,902 $1.91 Million
Q4 2022

Feb 14, 2023

BUY
$95.06 - $111.52 $552,488 - $648,154
5,812 Added 62.84%
15,061 $1.65 Million
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $93,470 - $108,220
966 Added 11.66%
9,249 $895,000
Q2 2022

Aug 15, 2022

SELL
$102.07 - $123.37 $1.03 Million - $1.24 Million
-10,074 Reduced 54.88%
8,283 $900,000
Q1 2022

May 16, 2022

BUY
$114.02 - $139.04 $2.09 Million - $2.55 Million
18,357 New
18,357 $2.17 Million
Q4 2021

Feb 14, 2022

SELL
$115.53 - $141.46 $5.07 Million - $6.2 Million
-43,854 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$116.66 - $129.06 $1.25 Million - $1.39 Million
10,756 Added 32.5%
43,854 $5.18 Million
Q2 2021

Aug 16, 2021

BUY
$105.79 - $124.53 $979,932 - $1.15 Million
9,263 Added 38.86%
33,098 $3.84 Million
Q1 2021

May 17, 2021

SELL
$108.84 - $128.23 $4.13 Million - $4.86 Million
-37,908 Reduced 61.4%
23,835 $2.86 Million
Q4 2020

Feb 16, 2021

BUY
$105.0 - $114.42 $4.32 Million - $4.7 Million
41,106 Added 199.19%
61,743 $6.76 Million
Q3 2020

Nov 16, 2020

BUY
$91.64 - $111.29 $183,646 - $223,025
2,004 Added 10.76%
20,637 $2.25 Million
Q2 2020

Aug 14, 2020

SELL
$76.57 - $98.0 $852,147 - $1.09 Million
-11,129 Reduced 37.39%
18,633 $1.7 Million
Q1 2020

May 15, 2020

SELL
$62.82 - $91.86 $5.82 Million - $8.5 Million
-92,575 Reduced 75.67%
29,762 $2.35 Million
Q4 2019

Feb 14, 2020

BUY
$78.51 - $87.4 $4.71 Million - $5.24 Million
60,003 Added 96.26%
122,337 $10.6 Million
Q3 2019

Nov 14, 2019

BUY
$81.84 - $88.74 $5.1 Million - $5.53 Million
62,334 New
62,334 $5.22 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track Lee Ainslie's Portfolio

Track Lee Ainslie Portfolio

Follow Lee Ainslie (Maverick Capital LTD) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.